Plasma proteomic associations with genetics and health in the UK Biobank
2023/10/04 by Benjamin B. Sun, Joshua Chiou, Matthew Traylor +61 · 48 citations
Biochemistry, Genetics and Molecular Biology · #Cancer Genomics and Diagnostics #Genetic Associations and Epidemiology #Genomics and Rare Diseases
paper · pdf · doi:10.1038/s41586-023-06592-6
openalex publication_date 2023/10/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Abstract
Abstract The Pharma Proteomics Project is a precompetitive biopharmaceutical consortium characterizing the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a detailed summary of this initiative, including technical and biological validations, insights into proteomic disease signatures, and prediction modelling for various demographic and health indicators. We present comprehensive protein quantitative trait locus (pQTL) mapping of 2,923 proteins that identifies 14,287 primary genetic associations, of which 81% are previously undescribed, alongside ancestry-specific pQTL mapping in non-European individuals. The study provides an updated characterization of the genetic architecture of the plasma proteome, contextualized with projected pQTL discovery rates as sample sizes and proteomic assay coverages increase over time. We offer extensive insights into trans pQTLs across multiple biological domains, highlight genetic influences on ligand–receptor interactions and pathway perturbations across a diverse collection of cytokines and complement networks, and illustrate long-range epistatic effects of ABO blood group and FUT2 secretor status on proteins with gastrointestinal tissue-enriched expression. We demonstrate the utility of these data for drug discovery by extending the genetic proxied effects of protein targets, such as PCSK9, on additional endpoints, and disentangle specific genes and proteins perturbed at loci associated with COVID-19 susceptibility. This public–private partnership provides the scientific community with an open-access proteomics resource of considerable breadth and depth to help to elucidate the biological mechanisms underlying proteo-genomic discoveries and accelerate the development of biomarkers, predictive models and therapeutics 1 .
Citations
Cited by
- What Are the Practical Applications of Single-Cell Proteomics?
- Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities
- Whole-genome sequencing of 490,640 UK Biobank participants
- Large language model-based biological age prediction in large-scale populations
- Evaluation of Olink Reveal Proximity Extension Assay for High-Throughput Proteomics: A Case Study Using NIST SRM 1950 and Spike-In Protein Standards
- Extensive modulation of the circulating blood proteome by hormonal contraceptive use across two population studies
- Sleep chart of biological ageing clocks in middle and late life
- Age modifies the association between sex and the plasma inflammatory proteome in treated HIV
- A standardized framework for circulating blood proteomics
- Large-scale genome-wide analyses with proteomics integration reveal novel loci and biological insights into frailty
- Proteomic landscape of Alzheimer’s disease: emerging technologies, advances and insights (2021 – 2025)
- Plasma proteomics links brain and immune system aging with healthspan and longevity
- The present and future of the Cancer Dependency Map
- Mechanism of age-related accumulation of mtDNA mutations in human blood
- Plant‐Based Meat Alternatives Intake and Its Association With Health Status Among Vegetarians of the UK Biobank Volunteer Population
- Mendelian randomisation with proxy exposures: challenges and opportunities
- Colorectal cancer molecular profiling: Opportunities for early detection
- Plasma proteome adaptations during feminizing gender-affirming hormone therapy
- Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes
- Multiomics in atherosclerotic cardiovascular disease
- Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis
- Periodic dietary restriction of animal products induces metabolic reprogramming in humans with effects on cardiometabolic health
- Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues
- Biological aging and generational shifts in early-onset cancer risk
- Valid inference for machine learning-assisted genome-wide association studies
- Universal transcriptomic hallmarks of mammalian ageing and mortality
- Mendelian randomization with proxy exposures: challenges and opportunities
- Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
- Loss of CFHR5 function reduces the risk for age-related macular degeneration
- Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases
- Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort
- Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality
- Metabolically and epigenetically reprogrammed splenic TRNP1hiCD8+ T cells exacerbate liver fibrosis
- Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank
- Atlas of the plasma proteome in health and disease in 53,026 adults
- Next-generation proteomics in medical laboratories: metrologically sound quantitative protein tests vs. innovative and personalized proteome patterns
- Mendelian Randomization Methods for Causal Inference: Estimands, Identification and Inference
- Adaptive Bayesian computation for efficient biobank-scale genomic inference
- Assessing the causal relationship between the plasma proteome and epilepsy: A Mendelian randomization study
- Plasma proteome and incident myocardial infarction: sex-specific differences
- Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes
- Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes
- Determining the driving factors shaping genetic architecture of complex traits in recently admixed populations
- Deciphering the multi-target mechanisms of TCM formulas in hyperlipidemia treatment through meta-multi-omics data and UK Biobank analysis
- Advancing regulatory variant effect prediction with AlphaGenome
- Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma
- Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology
- The lactylation–immune regulatory axis: a potential therapeutic target for migraine prevention and treatment
Related